A proinsulin74-90-derived protease-resistant, altered peptide ligand increases TGF-β1 secretion in PBMC from patients with type 1 diabetes mellitus

Journal of Leukocyte Biology

Volumn 87, Issue 5, 2010, Pages 943-948

  Van Aalst, Denise ^a   Kalbacher, Hubert ^b   Palesch, David ^a   Zou, Fang ^a   Spyrantis, Andreas ^a   Rosinger, Silke ^a   Boehm, Bernhard O ^a   Burster, Timo ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Antigens; Autoimmune; Epitope; Primary cells

Indexed keywords

AMINO ACID; CYTOKINE; PROINSULIN; PROTEIN P17; PROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; AUTOANTIGEN; LIGAND;

ARTICLE; DIABETES MELLITUS; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN SECRETION; T LYMPHOCYTE; AMINO ACID SEQUENCE; CELL SEPARATION; CHEMISTRY; FLOW CYTOMETRY; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; MONONUCLEAR CELL; SECRETION;

AMINO ACID SEQUENCE; AUTOANTIGENS; CELL SEPARATION; DIABETES MELLITUS, TYPE 1; FLOW CYTOMETRY; HUMANS; LEUKOCYTES, MONONUCLEAR; LIGANDS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PROINSULIN; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77952468510     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1109713     Document Type: Article

References (20)

1. Jasinski, J. M., Eisenbarth, G. S. (2005) Insulin as a primary autoantigen for type 1A diabetes. Clin. Dev. Immunol. 12, 181-186. (Pubitemid 43205642)
2. Baekkeskov, S., Aanstoot, H. J., Christgau, S., Reetz, A., Solimena, M., Cascalho, M., Folli, F., Richter-Olesen, H., De Camilli, P. (1990) Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347, 151-156.
3. Boehm, B. O., Bluestone, J. A. (2004) Differential roles of costimulatory signaling pathways in type 1 diabetes mellitus. Rev. Diabet. Stud. 1, 156-164.
4. Eisenbarth, G. S. (2007) Update in type 1 diabetes. J. Clin. Endocrinol. Metab. 92, 2403-2407.
5. Adorini, L., Muller, S., Cardinaux, F., Lehmann, P. V., Falcioni, F., Nagy, Z. A. (1988) In vivo competition between self peptides and foreign antigens in T-cell activation. Nature 334, 623-625.
6. Johnson, K. P., Brooks, B. R., Cohen, J. A., Ford, C. C., Goldstein, J., Lisak, R. P., Myers, L. W., Panitch, H. S., Rose, J. W., Schiffer, R. B. (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing- remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group. Neurology 45, 1268-1276.
7. Weldon, J. E., Xiang, L., Chertov, O., Margulies, I., Kreitman, R. J., FitzGerald, D. J., Pastan, I. (2009) A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity. Blood 113, 3792-3800.
8. Tselios, T., Apostolopoulos, V., Daliani, I., Deraos, S., Grdadolnik, S., Mavromoustakos, T., Melachrinou, M., Thymianou, S., Probert, L., Mouzaki, A., Matsoukas, J. (2002) Antagonistic effects of human cyclic MBP(87-99) altered peptide ligands in experimental allergic encephalomyelitis and human T-cell proliferation. J. Med. Chem. 45, 275-283.
9. Lamont, A. G., Powell, M. F., Colon, S. M., Miles, C., Grey, H. M., Sette, A. (1990) The use of peptide analogs with improved stability and MHC binding capacity to inhibit antigen presentation in vitro and in vivo. J. Immunol. 144, 2493-2498. (Pubitemid 20136648)
10. Burster, T., Marin-Esteban, V., Boehm, B. O., Dunn, S., Rotzschke, O., Falk, K., Weber, E., Verhelst, S. H., Kalbacher, H., Driessen, C. (2007) Design of protease-resistant myelin basic protein-derived peptides by cleavage site directed amino acid substitutions. Biochem. Pharmacol. 74, 1514-1523. (Pubitemid 47575491)
11. Boehm, B. O., Rosinger, S., Sauer, G., Manfras, B. J., Palesch, D., Schiekofer, S., Kalbacher, H., Burster, T. (2009) Protease-resistant human GAD-derived altered peptide ligands decrease TNF-α and IL-17 production in peripheral blood cells from patients with type 1 diabetes mellitus. Mol. Immunol. 46, 2576-2584.
12. Max, H., Halder, T., Kalbus, M., Gnau, V., Jung, G., Kalbacher, H. (1994) A 16mer peptide of the human autoantigen calreticulin is a most prominent HLA-DR4Dw4-associated self-peptide. Hum. Immunol. 41, 39-45. (Pubitemid 24319048)
13. Durinovic-Bello, I., Rosinger, S., Olson, J. A., Congia, M., Ahmad, R. C., Rickert, M., Hampl, J., Kalbacher, H., Drijfhout, J. W., Mellins, E. D., Al Dahouk, S., Kamradt, T., Maeurer, M. J., Nhan, C., Roep, B. O., Boehm, B. O., Polychronakos, C., Nepom, G. T., Karges, W., McDevitt, H. O., Sønderstrup, G. (2006) DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotype. Proc. Natl. Acad. Sci. USA 103, 11683-11688.
14. Bettelli, E., Korn, T., Oukka, M., Kuchroo, V. K. (2008) Induction and effector functions of T(H)17 cells. Nature 453, 1051-1057. (Pubitemid 351871737)
15. Bach, J. F. (2003) Autoimmune diseases as the loss of active "self-control". Ann. N. Y. Acad. Sci. 998, 161-177.
16. Bettini, M., Vignali, D. A. (2009) Regulatory T cells and inhibitory cytokines in autoimmunity. Curr. Opin. Immunol. 21, 612-618.
17. Tang, Q., Bluestone, J. A. (2008) The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9, 239-244. (Pubitemid 351267321)
18. Brusko, T. M., Putnam, A. L., Bluestone, J. A. (2008) Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol. Rev. 223, 371-390. (Pubitemid 351986182)
19. Ueda, H., Howson, J. M., Esposito, L., Heward, J., Snook, H., Chamberlain, G., Rainbow, D. B., Hunter, K. M., Smith, A. N., Di Genova, G., et al. (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506-511. (Pubitemid 36648570)
20. Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., Sakaguchi, S. (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science 322, 271-275.